U.S. market Closed. Opens in 1 day 11 hours 15 minutes

GALT | Galectin Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue33.00K32.00K41.00K36.00K35.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-33.00K-32.00K-41.00K-36.00K-35.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses38.07M38.35M30.18M23.44M13.44M13.60M16.25M21.48M20.08M15.43M12.10M9.90M10.41M4.88M6.09M5.33M6.46M7.05M6.66M7.30M4.94M3.29M2.18M170.00K
Selling, General & Admin5.94M6.62M6.36M5.47M5.97M7.13M4.53M6.16M6.96M7.00M6.42M5.37M6.86M3.82M4.98M3.55M4.40M4.03M3.62M4.26M2.99M1.80M1.29M70.00K
Research & Development32.13M31.74M23.82M17.98M7.47M6.47M11.72M15.32M13.11M8.43M5.69M4.53M3.55M1.07M1.11M1.77M2.05M3.02M3.04M3.04M1.95M1.48M893.46K100.00K
Other Operating Expenses0N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-38.07M-38.35M-30.18M-23.44M-13.44M-13.60M-16.25M-21.48M-20.08M-15.43M-12.10M-9.90M-10.41M-4.88M-6.09M-5.33M-6.46M-7.05M-6.66M-7.30M-4.94M-3.29M-2.18M-170.00K
Other Expenses / Income-2.99M-424.00K-348.00K-21.00K144.00K-298.00K12.00K45.00K52.00K-358.00K16.00K224.00K-524.00K-752.00K-1.37M2.15M-2.73M5.42MN/AN/AN/AN/AN/A-20.00K
Before Tax Income-41.07M-38.78M-30.53M-23.46M-13.29M-13.90M-16.23M-21.44M-20.03M-15.79M-12.09M-9.68MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-190.00K
Income Tax Expenses-2.99M424.00K448.00K51.00K87.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-41.07M-39.20M-30.98M-23.52M-13.38M-13.90M-16.23M-21.44M-20.03M-15.79M-12.09M-9.68M-10.91M-5.63M-7.46M-3.15M-9.43M-3.19M-6.54M-7.18M-4.87M-3.68M-3.97M-190.00K
Interest Expenses-2.79M1.03M489.00K87.00K87.00K336.00K12.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding55.14M59.39M58.53M57.03M52.24M39.41M35.52M29.22M24.12M21.85M16.87M15.13M11.99M9.38M8.05M7.80M6.50M4.75M4.55M4.29M3.56M2.73M2.27M2.06M
Diluted Shares Outstanding60.16M59.39M58.53M57.03M52.24M39.41M35.52M29.22M24.12M21.85M16.87M15.13M11.99M9.38M8.05M7.80M6.50M4.75M4.55M4.29M3.56M2.73M2.27M2.06M
EBITDA-6.73M-38.30M-30.18M-23.38M-13.17M-13.56M-16.22M-21.47M-20.07M-15.42M-12.09M-9.89M-10.40M-4.87M-6.06M-5.28M-6.39M-6.98M-6.57M-7.22M-4.85M-3.08M-2.02M-190.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-46.85M-37.74M-30.04M-23.38M-13.21M-13.56M-16.22M-21.44M-20.03M-15.79M-12.09M-9.68M-10.91M-5.63M-7.46M-3.15M-9.43M-3.19M-6.54M-7.18M-4.87M-3.68M-3.97M-190.00K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙